- Nachrichtendetail
-
09.05.2024 13:07:51 - dpa-AFX: *MERCK: HEALTH CANADA APPROVES KEYTRUDA + GEMCITABINE-BASED CHEMOTHERAPY FOR BILIARY TRACT CARCINOMA IN ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 131,100 | 23.05.24 21:29:17 | ±0,000 | ±0,00% | 131,100 | 131,110 | 130,900 | 131,100 |
